Patents by Inventor Jose Luis Velada

Jose Luis Velada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210299146
    Abstract: Described herein are synthetic progestogens, such as 6?,7?:15?,16?-Dimethylene-3-oxo-17?-pregn-4-ene-21,17-carbolactone, as well as pharmaceutical compositions comprising the same. Also described are methods of use.
    Type: Application
    Filed: June 11, 2021
    Publication date: September 30, 2021
    Inventors: Philippe PERRIN, Jose Luis VELADA, Dominique DROUIN
  • Patent number: 11123299
    Abstract: Described herein are synthetic progestogens, such as 6?,7?:15?,16?-Dimethylene-3-oxo-17?-pregn-4-ene-21,17-carbolactone, as well as pharmaceutical compositions comprising the same. Also described are methods of use.
    Type: Grant
    Filed: March 29, 2021
    Date of Patent: September 21, 2021
    Assignee: LABORATORIOS LEON FARMA SA
    Inventors: Philippe Perrin, Jose Luis Velada, Dominique Drouin
  • Publication number: 20210213035
    Abstract: Described herein are synthetic progestogens, such as 6?,7?:15?,16?-Dimethylene-3-oxo-17?-pregn-4-ene-21,17-carbolactone, as well as pharmaceutical compositions comprising the same. Also described are methods of use.
    Type: Application
    Filed: March 29, 2021
    Publication date: July 15, 2021
    Inventors: Philippe PERRIN, Jose Luis VELADA, Dominique DROUIN
  • Publication number: 20210128585
    Abstract: Described herein are synthetic progestogens, such as 6?,7?:15?,16?-Dimethylene-3-oxo-17?-pregn-4-ene-21,17-carbolactone, as well as pharmaceutical compositions comprising the same. Also described are methods of use.
    Type: Application
    Filed: November 25, 2020
    Publication date: May 6, 2021
    Inventors: Philippe PERRIN, Jose Luis VELADA, Dominique DROUIN
  • Publication number: 20210128586
    Abstract: Described herein are methods to size particles of 6?,7?:15?,16?-Dimethylene-3-oxo-17?-pregn-4-ene-21,17-carbolactone, as well as compositions comprising 6?,7?:15?,16?-Dimethylene-3-oxo-17?-pregn-4-ene-21,17-carbolactone particles having defined particle size distributions. Also described are methods of use of the resulting particles.
    Type: Application
    Filed: November 25, 2020
    Publication date: May 6, 2021
    Inventors: Philippe PERRIN, Jose Luis VELADA, Dominique DROUIN
  • Patent number: 10987364
    Abstract: Described herein are synthetic progestogens, such as 6?,7?:15?,16?-Dimethylene-3-oxo-17?-pregn-4-ene-21,17-carbolactone, as well as pharmaceutical compositions comprising the same. Also described are methods of use.
    Type: Grant
    Filed: November 25, 2020
    Date of Patent: April 27, 2021
    Assignee: LABORATORIOS LEON FARMA SA
    Inventors: Philippe Perrin, José Luis Velada, Dominique Drouin
  • Patent number: 10849857
    Abstract: The present invention relates to pharmaceutical compositions and kits comprising pharmaceutical compositions, and methods for administering pharmaceutical compositions comprising active contraceptive drugs in a patient. Specifically, the pharmaceutical compositions may comprise progestogen-only contraceptives (“POC”), such as Drospirenone.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: December 1, 2020
    Assignee: LABORATORIOS LEON FARMA SA
    Inventors: Philippe Perrin, Jose Luis Velada, Dominique Drounin
  • Patent number: 10603281
    Abstract: The present invention relates to pharmaceutical compositions and kits comprising pharmaceutical compositions, and methods for administering pharmaceutical compositions comprising active contraceptive drugs in a patient. Specifically, the pharmaceutical compositions may comprise progestogen-only contraceptive (“POC”), such as Drosphirenone.
    Type: Grant
    Filed: May 17, 2019
    Date of Patent: March 31, 2020
    Assignee: Laboratorios Leon Farma SA
    Inventors: Philippe Perrin, Jose Luis Velada, Dominique Drouin
  • Publication number: 20200054566
    Abstract: The present invention relates to pharmaceutical compositions and kits comprising pharmaceutical compositions, and methods for administering pharmaceutical compositions comprising active contraceptive drugs in a patient. Specifically, the pharmaceutical compositions may comprise progestogen-only contraceptives (“POC”), such as Drospirenone.
    Type: Application
    Filed: October 25, 2019
    Publication date: February 20, 2020
    Applicant: LABORATORIOS LEON FARMA SA
    Inventors: Philippe PERRIN, Jose Luis VELADA, Dominique DROUIN
  • Publication number: 20190282505
    Abstract: The present invention relates to pharmaceutical compositions and kits comprising pharmaceutical compositions, and methods for administering pharmaceutical compositions comprising active contraceptive drugs in a patient. Specifically, the pharmaceutical compositions may comprise progestogen-only contraceptive (“POC”), such as Drosphirenone.
    Type: Application
    Filed: May 17, 2019
    Publication date: September 19, 2019
    Applicant: LABORATORIOS LEON FARMA SA
    Inventors: Philippe PERRIN, Jose Luis VELADA, Dominique DROUIN
  • Publication number: 20190269620
    Abstract: The present invention relates to pharmaceutical compositions and kits comprising pharmaceutical compositions, and methods for administering pharmaceutical compositions comprising active contraceptive drugs in a patient. Specifically, the pharmaceutical compositions may comprise progestogen-only contraceptives (“POC”), such as Drospirenone.
    Type: Application
    Filed: May 17, 2019
    Publication date: September 5, 2019
    Applicant: LABORATORIOS LEON FARMA SA
    Inventors: Philippe PERRIN, Jose Luis VELADA, Dominique DROUIN
  • Publication number: 20170000727
    Abstract: The invention relates to a pharmaceutical dry enema product. Said product comprises mesalazine dry granules suitable for reconstitution into enema. The pharmaceutical product preferably is supplied in a package together with an enema bottle with one-way valve. The product can be easily dispersed and after reconstitution it has required viscosity to ensure uniform suspension of the drug and better retention in inflamed mucosa and it can be applied without loss or spillage of the pharmaceutical active ingredient.
    Type: Application
    Filed: December 18, 2014
    Publication date: January 5, 2017
    Applicant: DISPHAR INTERNATIONAL B.V.
    Inventors: José Luis VELADA, Hiteshkumar Anilkant DOSHI, Shruti Ashok HAZARE
  • Publication number: 20150119422
    Abstract: The present invention relates to solid pharmaceutical formulations based on simethicone and calcium phosphate and mannitol.
    Type: Application
    Filed: December 11, 2012
    Publication date: April 30, 2015
    Inventors: José Luis Velada, Hiteshkumar Anilkant Doshi, Anjali Rajesh Tendulkar, Vicky Shinde
  • Publication number: 20120128733
    Abstract: The present invention relates to pharmaceutical compositions and kits comprising pharmaceutical compositions, and methods for administering pharmaceutical compositions comprising active contraceptive drugs in a patient. Specifically, the pharmaceutical compositions may comprise progestogen-only contraceptives (“POC”), such as Drospirenone.
    Type: Application
    Filed: June 28, 2011
    Publication date: May 24, 2012
    Inventors: Philippe PERRIN, Jose Luis VELADA, Dominique DROUNIN
  • Publication number: 20100086499
    Abstract: The present invention provides an effective tooth whitening composition comprising a chlorine dioxide precursor, an organic acid anhydride and an orally acceptable carrier.
    Type: Application
    Filed: May 11, 2007
    Publication date: April 8, 2010
    Inventors: Gary Robert Burnett, Jennifer Jane Gordon, Jose Luis Velada
  • Publication number: 20090010970
    Abstract: The present invention provides a dissolvable strip for whitening teeth. The strip, which is preferably a single layer, has a whitening agent and a water-soluble or water dispersible polymer system. The dissolution of the whitening composition is controlled by interaction of the whitening composition with an oral environment containing saliva. The present invention further provides a process for preparing the whitening strip in the form of a dry film and a method of whitening teeth.
    Type: Application
    Filed: October 4, 2005
    Publication date: January 8, 2009
    Inventor: Jose Luis Velada
  • Publication number: 20080274067
    Abstract: An oral care composition comprising an active agent e.g. a whitening agent and a carrier including a carrier base comprising a wax and a substantivity agent. A method of whitening the teeth using the composition is also disclosed.
    Type: Application
    Filed: June 29, 2005
    Publication date: November 6, 2008
    Applicant: GLAXO GROUP LIMITED
    Inventors: Rachel Sarah Chaffer, Emma Jane Dewstowe, Robert John Gambogi, Jennifer Jane Gordon, Evelyn Elizabeth Newby, Jose Luis Velada